Menu

Gilead announced it will move its 340B contract pharmacy claims review and policy oversight duties from Second Sight Solutions’ 340B ESP to Kalderos’ Truzo as of June 15.

Gilead Latest Drugmaker to Move to Truzo, Kalderos’ Platform for 340B Contract Pharmacy Restrictions

May 5, 2026 Shannon Young, Managing Editor 340B Report Views

A California-based drugmaker recently announced that it will become the fourth drugmaker to utilize a new platform for its 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Bergman, Ruiz to Introduce Bipartisan Bill Exempting Additional Covered Entities From 340B Rebates

Maryland Officials Urge Appeals Court to Rehear State 340B Contract Pharmacy Case